[1,2-a]

[1,2-b]

[1,2-c]

[1,2-d]

[1,2-f]

[1,2-x]

[1,5-a]

[1,5-b]

[1,5-c]

[1,5-d]

[1,6-ad][1,7-a]

[2,1-a]

[2,1-b]

[2,1-c]

[2,1-d]

[2,1-e]

[2,1-f]

[2,1-]

[2,3-a]

[2,3-b]

[2,3-c]

[2,3-d]

[2,3-e]

[2,3-f]

[2,3-g]

[2,3-h]

[2,3-ij][2,4-b]

[3,2-a]

[3,2-b]

[3,2-c]

[3,2-d]

[3,2-e]

[3,2-g]

[3,2-f]

[3,2-h]

[3,4-a]

[3,4-b]

[3,4-c]

[3,4-d]

[3,4-e]

[3,4-f]

[3,4-g]

[3,4-]

[4,3-a]

[4,3-b]

[4,3-c]

[4,3-d]

[4,3-e]

[4,3-g]

[4,3-]

[4,5-a]

[4,5-b]

[4,5-c]

[4,5-d]

[4,5-e]

[4,5-f]

[4,5-g]

[4,5-h]

[4,5-]

[5,1-a]

[5,1-b]

[5,1-c]

[5,1-f]

[5,1-]

[5,4-b]

[5,4-c]

[5,4-d]

[5,4-e]

[5,4-f]

[5,4-]

[5,6-b]

[5,6-c]

[5,6-]

[6,1-b]

[6,1-]

[6,5-b]

[6,5-]

Order 8029-24-1 N-Cocotrimethylammonium chloride

Order 80292-71-3 Ethanone, 2-ethoxy-1-(2-ethoxyphenyl)-

Order 80292-74-6 &acirc

Order 8029-29-6 BANDANE

Order 802935-24-6 Glycinamide,N-[(1,1-dimethylethoxy)carbonyl]glycylglycyl-N-[4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-

Order 802935-55-3 3-Oxazolidinyloxy, 2-butyl-2-(13-methoxy-13-oxotridecyl)-4,4-dimethyl-

Order 80294-10-6 Pyridine, 2-bromo-3-(1-methyl-2-pyrrolidinyl)-, (S)-

Order 80294-22-0 bio-vitroceramic AP40

Order 80294-24-2 Epoxycal

Order 80295-34-7 COMPLEMENT C1R, HUMAN, ACTIVATED, TWO-CHAIN FORM

Order 80295-35-8 COMPLEMENT C1S, HUMAN, ACTIVATED, TWO-CHAIN FORM

Order 80295-37-0 Complement C1 inactivator

Order 80295-49-4 COMPLEMENT 4A

Order 80295-55-2 complement 5b

Order 80295-64-3 PROPERDIN

Order 80296-67-9 AC 119

Order 80297-84-3 2,5-Hexanediamine, (2R,5R)-

Order 802982-14-5 3-Butyn-1-ol, 4-[4-(3-bromopropoxy)phenyl]-

Order 802984-58-3 2-CYCLOHEXEN-1-ONE,3-METHOXY-4,4-DIMETHYL-2-PHENYL-

Order 802986-32-9 Ba.Ce.Mn.O.Pb.Ti